Biora Therapeutics (BIOR) Short Interest Ratio & Short Volume → The #1 lithium battery stock to have on your radar in 2024! (From Smallcaps Daily) (Ad) Free BIOR Stock Alerts $0.74 -0.01 (-1.04%) (As of 11:28 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Biora Therapeutics Short Interest DataCurrent Short Volume1,400,000 sharesPrevious Short Volume1,340,000 sharesChange Vs. Previous Month+4.48%Dollar Volume Sold Short$868,000.00Short Interest Ratio / Days to Cover3.2Last Record DateApril 15, 2024Outstanding Shares35,880,000 sharesFloat Size32,310,000 sharesShort Percent of Float4.33%Today's Trading Volume76,490 sharesAverage Trading Volume417,018 sharesToday's Volume Vs. Average18% Short Selling Biora Therapeutics ? Sign up to receive the latest short interest report for Biora Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBIOR Short Interest Over TimeBIOR Days to Cover Over TimeBIOR Percentage of Float Shorted Over Time Ad American Hartford Gold GroupTrump Asset Seizure Threat Alert: Could Your Savings Be Next?Trump Asset Seizures Threat A Warning For 401K Owners?Request Your FREE WEALTH PROTECTION GUIDE Biora Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20241,400,000 shares $868,000.00 +4.5%4.3%3.2 $0.62 3/31/20241,340,000 shares $1.47 million +13.6%4.2%2.9 $1.10 3/15/20241,180,000 shares $1.32 million +4.4%4.8%2.9 $1.12 2/29/20241,130,000 shares $1.48 million +58.1%4.6%2.6 $1.31 2/15/2024714,600 shares $578,111.40 +12.0%2.9%1.1 $0.81 1/31/2024638,300 shares $600,002.00 +7.8%2.5%1 $0.94 Get the Latest News and Ratings for BIOR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Biora Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024592,300 shares $746,298.00 +32.0%2.3%0.9 $1.26 12/31/2023448,800 shares $605,880.00 -33.5%1.7%0.8 $1.35 12/15/2023674,800 shares $917,728.00 +130.3%2.6%1.3 $1.36 11/30/2023293,000 shares $363,320.00 -55.2%1.3%0.6 $1.24 11/15/2023653,700 shares $875,958.00 +28.6%2.9%3.9 $1.34 10/31/2023508,200 shares $988,449.00 +7.4%2.3%3.8 $1.95 10/15/2023473,100 shares $865,773.00 +9.2%2.2%4.2 $1.83 9/30/2023433,300 shares $940,261.00 +38.5%2.0%4.8 $2.17 9/15/2023312,800 shares $706,928.00 +69.5%2.4%3.5 $2.26 8/31/2023184,600 shares $548,262.00 -9.0%1.5%1.6 $2.97 8/15/2023202,800 shares $636,792.00 -14.9%1.7%1.2 $3.14 7/31/2023238,300 shares $912,689.00 -12.8%1.9%1.3 $3.83 7/15/2023273,300 shares $1.09 million -26.3%2.1%1.5 $4.00 6/30/2023370,800 shares $1.43 million -9.6%2.9%2.1 $3.85 6/15/2023410,000 shares $1.75 million -0.3%3.2%2.2 $4.28 5/31/2023411,100 shares $1.84 million +5.2%3.6%2.4 $4.48 5/15/2023390,700 shares $1.31 million -7.7%3.5%2.8 $3.35 4/30/2023423,100 shares $1.03 million +0.2%3.7%3.1 $2.43 4/15/2023422,100 shares $1.10 million -0.1%4.8%1.6 $2.60 3/31/2023422,400 shares $1.17 million +24.5%4.8%0.2 $2.77 3/15/2023339,400 shares $868,864.00 -17.3%3.9%0.2 $2.56 2/28/2023410,200 shares $1.26 million -0.5%4.9%0.2 $3.06 2/15/2023412,400 shares $1.43 million -33.9%6.1%0.2 $3.46 1/31/2023623,900 shares $2.60 million -74.1%9.2%0.3 $4.17 1/15/20232,410,000 shares $10.29 million +428.5%35.4%1.1 $4.27 12/30/2022456,000 shares $37.53 million -96.1%6.7%0.5 $82.31 12/15/202211,730,000 shares $2.05 million -1.9%6.9%8.1 $0.17 11/30/202211,960,000 shares $2.93 million -7.6%7.1%9.1 $0.25 11/15/202212,950,000 shares $3.46 million -6.6%7.7%10.4 $0.27 10/31/202213,860,000 shares $5.28 million -2.5%8.4%8 $0.38 10/15/202214,210,000 shares $5.76 million +0.9%8.6%8.4 $0.41 9/30/202214,080,000 shares $6.83 million -4.4%8.5%8 $0.48 9/15/202214,730,000 shares $9.95 million -0.1%8.9%7.5 $0.68 8/31/202214,750,000 shares $10.65 million -7.1%8.9%7.2 $0.72Trump Asset Seizure Threat Alert: Could Your Savings Be Next? (Ad)Trump Asset Seizures Threat A Warning For 401K Owners?Request Your FREE WEALTH PROTECTION GUIDE BIOR Short Interest - Frequently Asked Questions What is Biora Therapeutics' current short interest? Short interest is the volume of Biora Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 1,400,000 shares of BIOR short. 4.33% of Biora Therapeutics' shares are currently sold short. Learn More on Biora Therapeutics' current short interest. What is a good short interest ratio for Biora Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BIOR shares currently have a short interest ratio of 3.0. Learn More on Biora Therapeutics's short interest ratio. Which institutional investors are shorting Biora Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Biora Therapeutics: Concourse Financial Group Securities Inc., and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Biora Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.33% of Biora Therapeutics' floating shares are currently sold short. Is Biora Therapeutics' short interest increasing or decreasing? Biora Therapeutics saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 1,400,000 shares, an increase of 4.5% from the previous total of 1,340,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Biora Therapeutics' float size? Biora Therapeutics currently has issued a total of 35,880,000 shares. Some of Biora Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Biora Therapeutics currently has a public float of 32,310,000 shares. How does Biora Therapeutics' short interest compare to its competitors? 4.33% of Biora Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Biora Therapeutics: Exagen Inc. (0.15%), Lumos Pharma, Inc. (5.83%), CytoMed Therapeutics Limited (0.99%), Cumberland Pharmaceuticals Inc. (0.22%), Lisata Therapeutics, Inc. (0.24%), Bullfrog AI Holdings, Inc. (5.49%), Oncternal Therapeutics, Inc. (0.52%), Lipocine Inc. (5.41%), Iterum Therapeutics plc (7.50%), Benitec Biopharma Inc. (0.50%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Biora Therapeutics stock? Short selling BIOR is an investing strategy that aims to generate trading profit from Biora Therapeutics as its price is falling. BIOR shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Biora Therapeutics? A short squeeze for Biora Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of BIOR, which in turn drives the price of the stock up even further. How often is Biora Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BIOR, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: XGN Short Interest LUMO Short Interest GDTC Short Interest CPIX Short Interest LSTA Short Interest BFRG Short Interest ONCT Short Interest LPCN Short Interest ITRM Short Interest BNTC Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BIOR) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersThe #1 lithium battery stock to have on your radar in 2024!Smallcaps DailyDave Ramsey Shocks Millions With US Dollar LunacyAmerican Hartford Gold GroupTrump is sounding the alarmPreserve GoldBiden’s Sneaky H.R. 5376 Is A Nightmare For Retirement SaversBirch GoldIs Tesla going out of business?DTIAI “wealth window” is closing June 25thParadigm PressThe 2024 crypto bull run has already started — don’t get left behindInvestorPlaceThe 2024 Gold Rush: Unleashing Market PotentialPriority Gold